Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy ; volume:81 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-15 ; date:12.2024
Cellular and molecular life sciences ; 81, Heft 1 (10.9.2024), 1-15, 12.2024
- Urheber
-
Panicucci, Chiara
Sahin, Eray
Bartolucci, Martina
Casalini, Sara
Brolatti, Noemi
Pedemonte, Marina
Baratto, Serena
Pintus, Sara
Principi, Elisa
D’Amico, Adele
Pane, Marika
Sframeli, Marina
Messina, Sonia
Albamonte, Emilio
Sansone, Valeria A.
Mercuri, Eugenio
Bertini, Enrico
Sezerman, Ugur
Petretto, Andrea
Bruno, Claudio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-024-05426-6
- URN
-
urn:nbn:de:101:1-2411242101206.882311268637
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Panicucci, Chiara
- Sahin, Eray
- Bartolucci, Martina
- Casalini, Sara
- Brolatti, Noemi
- Pedemonte, Marina
- Baratto, Serena
- Pintus, Sara
- Principi, Elisa
- D’Amico, Adele
- Pane, Marika
- Sframeli, Marina
- Messina, Sonia
- Albamonte, Emilio
- Sansone, Valeria A.
- Mercuri, Eugenio
- Bertini, Enrico
- Sezerman, Ugur
- Petretto, Andrea
- Bruno, Claudio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Spinal muscular atrophy
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Spinal muscular atrophy
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Spinal muscular atrophy
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy